Home Cart Sign in  
Chemical Structure| 1414963-82-8 Chemical Structure| 1414963-82-8

Structure of NK-252
CAS No.: 1414963-82-8

Chemical Structure| 1414963-82-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

NK-252 is a Nrf2 activator, exhibits a greater Nrf2-activating potential than OPZ.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of NK-252

CAS No. :1414963-82-8
Formula : C13H11N5O3
M.W : 285.26
SMILES Code : O=C(NCC1=NC=CC=C1)NC2=NN=C(C3=CC=CO3)O2
MDL No. :MFCD28009512
InChI Key :FNSCFQXZZNCDAI-UHFFFAOYSA-N
Pubchem ID :71618700

Safety of NK-252

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
P388/VCR cells 5 μg/ml and 10μg/ml 4 days NK-252 almost completely overcame the cross-resistance to etoposide of P388/VCR cells PMC1977534
P388/S cells 5μg/ml and 10μg/ml 4 days NK-252 potentiated the cytotoxic action of etoposide against P388/S cells PMC1977534
HT29 cells 200 µM Activate the Nrf2 signaling pathway, reversing oxaliplatin-induced ferroptosis and oxidative stress PMC9047032

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CD2F1 mice P388/S and P388/VCR leukemia mouse model Oral 100, 300, 1000 mg/kg Once daily for 5 days NK-252 alone showed no antitumour activity in P388/S- and P388/VCR-mice, but significantly extended the survival time when combined with etoposide PMC1977534

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.51mL

0.70mL

0.35mL

17.53mL

3.51mL

1.75mL

35.06mL

7.01mL

3.51mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories